119 related articles for article (PubMed ID: 341133)
1. Assessment of whole blood for antibody-dependent cell-mediated cytotoxicity in kidney patients.
Dupont E
Proc Eur Dial Transplant Assoc; 1977; 14():321-7. PubMed ID: 341133
[TBL] [Abstract][Full Text] [Related]
2. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
Dickmeiss E
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects of allograft rejection.
Williams GM
Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
[No Abstract] [Full Text] [Related]
4. Steroid sensitivity of chronic uraemic and renal transplant patients measured by the antibody dependent cellular cytotoxicity reaction.
Petri I; Csajbók E; Kiss E; Szenohradszky P; Kaiser G; Gál G
Haematologia (Budap); 1985; 18(4):225-32. PubMed ID: 3915294
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte dependent antibody (LDA) test in renal transplanted patients.
Wojtulewicz-Kurkus J; Podobińska I; Rowińska D; Lao M; Gutowska-Jablońska M; Orłowski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):991-5. PubMed ID: 373697
[TBL] [Abstract][Full Text] [Related]
6. [Antibody-dependent cell cytotoxicity and spontaneous cytotoxicity of peripheral blood lymphocytes of organ recipients and cells infiltrating the kidney allogeneic transplant].
Drannik GN; Baran EIa; Seniuk OF; Driianskaia VE
Fiziol Zh (1978); 1989; 35(5):68-72. PubMed ID: 2591583
[TBL] [Abstract][Full Text] [Related]
7. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
[TBL] [Abstract][Full Text] [Related]
8. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.
Santoli D; Trinchieri G; Moretta L; Zmijewski CM; Koprowski H
Clin Exp Immunol; 1978 Aug; 33(2):309-18. PubMed ID: 719952
[TBL] [Abstract][Full Text] [Related]
10. Immunologic monitoring of the renal transplant recipient.
Suthanthiran M; Garovoy MR
Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
[No Abstract] [Full Text] [Related]
11. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
Dickmeiss E
Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222
[TBL] [Abstract][Full Text] [Related]
12. Analyses of histocompatibility in cadaver renal transplantation.
Morris PJ
Transplant Proc; 1971 Jun; 3(2):1030-5. PubMed ID: 4944045
[No Abstract] [Full Text] [Related]
13. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.
Prince HE; Ettenger RB; Dorey FJ; Fine RN; Fahey JL
Transplant Proc; 1984 Dec; 16(6):1475-7. PubMed ID: 6390849
[No Abstract] [Full Text] [Related]
14. Detection of antidonor antibody: advantages of fibroblast target cells.
Halloran PF; Aprile M; Haddad G; Robinette M
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():49-55. PubMed ID: 386320
[TBL] [Abstract][Full Text] [Related]
15. Patterns of immunological anti-donor reactivity in renal allotransplanted patients--a prospective study.
Kristensen T; Grunnet N; Hansen HE; Fjeldborg O; Olsen S; Jørgensen F; Kissmeyer-Nielsen F
Scand J Urol Nephrol Suppl; 1977; (42):46-50. PubMed ID: 356221
[TBL] [Abstract][Full Text] [Related]
16. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
Warnatz H; Rösch W; Gerlich W; Gutmann W
Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
[TBL] [Abstract][Full Text] [Related]
18. Influence of azathioprine and prednisone in vivo treatment on lymphocyte-dependent antibody-mediated cytotoxicity (LDAC) in 57 human renal allograft recipients.
Descamps B; Gagnon R; van Der Gaag R; Meyer O; Crosnier J
Transplant Proc; 1977 Mar; 9(1):981-4. PubMed ID: 325832
[No Abstract] [Full Text] [Related]
19. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of rejection.
Stiller CR; Sinclair NR
Transplant Proc; 1979 Mar; 11(1):343-9. PubMed ID: 377654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
